Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Authors : Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, *Pais P*, *Xavier D*, Atisso CM, et al..

Publication Year : 2019

Abstract :

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31150-X/abstract